Focus on research: weighing the benefits and costs of HPV vaccination of young men

N Engl J Med. 2011 Feb 3;364(5):393-5. doi: 10.1056/NEJMp1012246.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Cost-Benefit Analysis
  • Disease Transmission, Infectious / prevention & control
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Male
  • Papillomavirus Infections / economics
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Infections / transmission
  • Papillomavirus Vaccines / economics*
  • Sexually Transmitted Diseases, Viral / prevention & control*
  • United States
  • Uterine Cervical Neoplasms / prevention & control
  • Young Adult

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines